Weight Loss Drug Will Be Taken Off the Market Due to Cancer Risk

17:55 EST 17 Feb 2020 | NEJM

Late last week, the FDA requested the voluntary withdrawal of the weight loss drug lorcaserin (Belviq, Belviq XR) from the market, stating that the drug's...

Original Article: Weight Loss Drug Will Be Taken Off the Market Due to Cancer Risk

More From BioPortfolio on "Weight Loss Drug Will Be Taken Off the Market Due to Cancer Risk"